Ambience Pharma
Levosulpiride (75mg) + Pantoprazole (40mg)
Zanpick L 75mg/40mg Capsule SR is a medicine used to treat gastroesophageal reflux disease (acid reflux) by relieving the symptoms of acidity such as heartburn, stomach pain, or irritation.
Capsule SR
Zanpick L 75mg/40mg Capsule SR is a medicine used to treat gastroesophageal reflux disease (acid reflux) by relieving the symptoms of acidity such as heartburn, stomach pain, or irritation. It also neutralizes the acid and promotes easy passage of gas to reduce stomach discomfort.
Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush or break it. Zanpick L 75mg/40mg Capsule SR is to be taken empty stomach.
Zanpick L 75mg/40mg Capsule SR is a combination of two medicines: Levosulpiride and Pantoprazole.
Take it one hour before the meal, preferably in the morning. Inform your doctor if you get watery diarrhea or stomach pain that does not go away. Do not consume alcohol while taking Zanpick L 75mg/40mg Capsule SR as it can increase the risk of stomach damage. Long-term use may cause weak or broken bones. Take adequate intake of dietary calcium and vitamin D or their supplements. Zanpick L 75mg/40mg Capsule SR is prescribed to give relief from acidity and its associated symptoms.
Take Zanpick L 75mg/40mg Capsule SR exactly as directed by your doctor. It is generally recommended to take one capsule on an empty stomach daily.
The use of Zanpick L 75mg/40mg Capsule SR should be avoided in patients with known allergy to any of the components or excipients of this medicine, including lactose.
Yes, some people taking Zanpick L 75mg/40mg Capsule SR may experience dizziness (feeling faint, weak, unsteady or lightheaded). If you experience dizziness, it is recommended to rest for a while and resume your routine only when you feel better.
There are studies that suggest Zanpick L 75mg/40mg Capsule SR may increase the risk of osteoporosis-related fractures, particularly of the hip, wrist, and spine. This risk is generally higher in patients receiving high doses of the medication, especially those with long-term therapy (e.g., one year or longer).